Items per page
Sort by

Send to:

Choose Destination

Results: 19


High-grade endometrial stromal sarcoma as the initial presentation of an adult patient with Peutz-Jeghers Syndrome: a case report.

Noriega-Iriondo MF, Colon-Otero G, Kipp BR, Copland JA, Ferber MJ, Marlow LA, Roberts ME, Robertson MW, Dinh TA, Attia S, Geiger XJ, Riegert-Johnson DL.

Hered Cancer Clin Pract. 2015 Jan 23;13(1):6. doi: 10.1186/s13053-015-0027-0. eCollection 2015.


Follicular Dendritic Cell Sarcoma Presenting As a Thyroid Mass.

Starr JS, Attia S, Joseph RW, Menke D, Casler J, Smallridge RC.

J Clin Oncol. 2014 Mar 24. [Epub ahead of print] No abstract available.


Dramatic response to pazopanib in a patient with metastatic malignant granular cell tumor.

Conley AP, Koplin S, Caracciollo JT, Reed DR, Webber NP, Attia S.

J Clin Oncol. 2014 Nov 10;32(32):e107-10. doi: 10.1200/JCO.2012.47.1078. Epub 2014 Feb 18. No abstract available.


Diffuse skeletal muscle metastases from sacral chordoma.

Carey K, Bestic J, Attia S, Cortese C, Jain M.

Skeletal Radiol. 2014 Jul;43(7):985-9. doi: 10.1007/s00256-013-1794-1. Epub 2014 Jan 10. Review.


A phase I study of vorinostat in combination with bortezomib in patients with advanced malignancies.

Schelman WR, Traynor AM, Holen KD, Kolesar JM, Attia S, Hoang T, Eickhoff J, Jiang Z, Alberti D, Marnocha R, Reid JM, Ames MM, McGovern RM, Espinoza-Delgado I, Wright JJ, Wilding G, Bailey HH.

Invest New Drugs. 2013 Dec;31(6):1539-46. doi: 10.1007/s10637-013-0029-6. Epub 2013 Oct 10.


Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience.

Buehler D, Rice SR, Moody JS, Rush P, Hafez GR, Attia S, Longley BJ, Kozak KR.

Am J Clin Oncol. 2014 Oct;37(5):473-9. doi: 10.1097/COC.0b013e31827e4e7b.


Metastatic Kaposi's Sarcoma with Perirectal Involvement Diagnosed with Endoscopic Ultrasound-Guided EchoBrush Cytology Sampling.

Cornett D, Benson M, Attia S, Weiss J, Gopal D.

Case Rep Gastroenterol. 2011 May;5(2):416-21. doi: 10.1159/000330480. Epub 2011 Jul 22.


AIDS-related Kaposi's sarcoma of the gastrointestinal tract.

Attia S, Dezube BJ, Torrealba JR, Sosman JM, McHaffie DR, Pfau PR, Bailey HH, Kozak KR.

J Clin Oncol. 2010 Jun 1;28(16):e250-1. doi: 10.1200/JCO.2009.26.5868. Epub 2010 May 3. No abstract available.


Metastatic soft tissue sarcoma diagnosed by small bowel video capsule endoscopy.

Weiss JM, Attia S, Bailey HH, Weber S, Hu J, Reichelderfer M, Gopal DV.

J Clin Oncol. 2010 May 20;28(15):e233-5. doi: 10.1200/JCO.2009.25.9143. Epub 2010 Apr 5. No abstract available.


Stewart-Treves syndrome of the lower extremity.

McHaffie DR, Kozak KR, Warner TF, Cho CS, Heiner JP, Attia S.

J Clin Oncol. 2010 Jul 20;28(21):e351-2. doi: 10.1200/JCO.2009.26.0406. Epub 2010 Apr 5. No abstract available.


Evaluation of mRNA by Q-RTPCR and protein expression by AQUA of the M2 subunit of ribonucleotide reductase (RRM2) in human tumors.

Kolesar J, Huang W, Eickhoff J, Hahn K, Alberti D, Attia S, Schelman W, Holen K, Traynor A, Ivy P, Wilding G.

Cancer Chemother Pharmacol. 2009 Jun;64(1):79-86. doi: 10.1007/s00280-008-0845-0. Epub 2008 Oct 22.


Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.

Attia S, Morgan-Meadows S, Holen KD, Bailey HH, Eickhoff JC, Schelman WR, Traynor AM, Mulkerin DL, Campbell TC, McFarland TA, Huie MS, Cleary JF, Tevaarwerk AJ, Alberti DB, Wilding G, Liu G.

Cancer Chemother Pharmacol. 2009 Jun;64(1):45-51. doi: 10.1007/s00280-008-0844-1. Epub 2008 Oct 8.


Phase I/II study of vinorelbine and exisulind as first-line treatment of advanced non-small cell lung cancer in patients at least 70 years old: a wisconsin oncology network study.

Attia S, Traynor AM, Kim K, Merchant JJ, Hoang T, Ahuja HG, Beatty PA, Hansen RM, Masters GA, Oettel KR, Shapiro GR, Larson MM, Larson ML, Schiller JH.

J Thorac Oncol. 2008 Sep;3(9):1018-25. doi: 10.1097/JTO.0b013e3181834fa1.


Prostate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions.

Shaw A, Attia S, Bushman W.

Differentiation. 2008 Jul;76(6):599-605. doi: 10.1111/j.1432-0436.2008.00275.x. Epub 2008 May 7. Review.


Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer.

Attia S, Eickhoff J, Wilding G, McNeel D, Blank J, Ahuja H, Jumonville A, Eastman M, Shevrin D, Glode M, Alberti D, Staab MJ, Horvath D, Straus J, Marnocha R, Liu G.

Clin Cancer Res. 2008 Apr 15;14(8):2437-43. doi: 10.1158/1078-0432.CCR-07-4274.


Biologic study of the effects of octreotide-LAR on growth hormone in unresectable and metastatic hepatocellular carcinoma.

Attia S, Holen KD, Thomas JP, Richie K, Dzelak T, Teeter K, Warren D, Bilger A, Fine J, Eickhoff J, Drinkwater N, Mulkerin D, Morgan-Meadows S.

Clin Adv Hematol Oncol. 2008 Jan;6(1):44-54.


A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.

Attia S, Kolesar J, Mahoney MR, Pitot HC, Laheru D, Heun J, Huang W, Eickhoff J, Erlichman C, Holen KD.

Invest New Drugs. 2008 Aug;26(4):369-79. doi: 10.1007/s10637-008-9123-6. Epub 2008 Feb 16.


Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer.

Bailey HH, Attia S, Love RR, Fass T, Chappell R, Tutsch K, Harris L, Jumonville A, Hansen R, Shapiro GR, Stewart JA.

Cancer Chemother Pharmacol. 2008 Jun;62(1):149-57. Epub 2007 Sep 21.


Novel antioxidant technology for prostate cancer chemoprevention and treatment.

Attia S, Wilding G.

Expert Opin Ther Pat. 2006 Sep;16(9):1255-67. doi: 10.1517/13543776.16.9.1255.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk